期刊文献+

不同细胞因子组合对脐带血AC133^+细胞体外扩增效率的影响

Effects of Different Cytokine Combinations on the Ex-vivo Expansion of Umbilical Cord Blood AC133^+ Cells
下载PDF
导出
摘要 目的探讨不同细胞因子组合对脐带血AC133+细胞体外扩增效率的影响。方法采用免疫荧光标记法,使用流式细胞仪测定新鲜分离的、不同培养条件下体外培养7、14d的脐带血AC133+细胞的扩增效率。结果新鲜脐带血AC133+细胞的比例为(0.93±0.2)%。短期液体扩增培养后,脐带血AC133+细胞的比例发生明显变化,其中在细胞因子SCF、FL和IL-3组合下,AC133+细胞的细胞数及扩增倍数与SCF、FL和IL-11组合相比较,差异非常显著(P<0.01)。结论在体外短期扩增培养中,早期效应细胞因子能显著上调脐带血AC133+细胞的比例;用SCF、FL和IL-3组合扩增脐带血造血干/祖细胞,能够获得更高的体外扩增效率。 Objective To investigate the effects of different cytokine combinations on the ex-vivo expansion of umbilical cord blood AC133 + cells. Methods The expansion efficiency of the umbilical cord blood AC133 + cells which were freshly isolated and incubated in serum-free liquid culture system for 7 d and 17 d with different cytokine combinations in vitro were analyzed by flow cytometric im-munoflurescence methods. Results Frequency of AC133+ cells in the freshly isolated umbilical cord blood mononuclear cells only was a significantly low (0.93% ±0.2 SEM). After short-term incubation in culture system with cytokines in vitro, the percentage of AC133+ cells increased. The total number and expansion was remarkably higher in the presence of IL-3, FL and SCF combination than that in the presence of IL-11, FL and SCF combination. There were significant difference between the two groups (P<0.01). Conclusion During short-term culture in vitro, the early-effective cytokines can up-regulate the percentage of AC133+ cells. In the presence of IL-3, FL and SCF combination, we may gain more expansion efficiency of the umbilical cord blood AC133+ cells than that in IL-11, FL and SCF combination.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2005年第1期7-9,44,共4页 Suzhou University Journal of Medical Science
基金 国防科工委"十五"国防预研项目资助课题(Y-020403-QS)
关键词 脐带血 AC133^+细胞 细胞因子 体外扩增 umbilical cord blood AC133+ cell cytokine ex-vivo expansion
  • 相关文献

参考文献8

  • 1Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietics stem and progenitor cells[J]. Blood, 1997, 90:5002-5012.
  • 2Miraglia S, Godfrey W, Yin AH, et al. A novel five transmembrane hematopoietics stem cell antigen: isolation, characterization, and molecular cloning[J]. Blood,1997, 90: 5013 - 5021.
  • 3Majka M, Ratajczak J, Machalinski B, et al. Expression, regulation and function of AC133, a putative cell surface marker of primitive human hematopoietics cells[J ]. Folia Histochem Cytobiol, 2000, 38:53 - 63.
  • 4Bhatia M. AC133 expression in human stem cells[J].Leukemia, 2001, 15: 1685 - 1688.
  • 5Gluckman E . Current status of umbilical cord blood hematopoietics stem cell transplantation[J ]. Experimen tal Hematology, 2000, 28:1297 - 1305.
  • 6Pasino M, Lanza T, Marotta F, et al. Flow cytometric and functional characterization of AC-133 + cells from human umbilical cord blood[J]. Br J Haematol, 2000, 108(4) :793 - 800.
  • 7de Wynter EA, Buck D, Hart C, et al. CD34+ AC133+cells isolated from cord blood are hightly enriched in longterm culture-initiating, NOD/SCID repopulating cells and dendritic cell progenitors[J]. Stem Cells, 1998, 16:387- 396.
  • 8Forraz N, Pettengell R, Deglesne PA, et al. AC133+umbilical cord blood progenitors demonstrate rapid selfrenewal and low apoptosis[J]. Br J Haematol, 2002,119:516- 524.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部